Codexis Inc.
CDXS - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$122.28M
Close$
$-2.83
348.4% downside
Current Fair Value
348.4% downsideOvervalued by 348.4% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $122.28 Million |
|---|---|
| Enterprise Value | $135.84 Million |
| Earnings per Share | $-0.5 |
| Beta | 2.55 |
| Outstanding Shares | 107,259,000 |
Return
| Return on Equity | -37.54% |
|---|---|
| Return on Assets | -13.34% |
| Return on Invested Capital | -14.28% |
Valuation & Multiples
| P/E Ratio | -5.92 |
|---|---|
| PEG | 10.11 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 1.54 |
| Enterprise Value to EBIT | -8.63 |
| Enterprise Value to Net Income | -8 |
| Total Debt to Enterprise | 0.31 |
| Debt to Equity | 0.83 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 12, 2026
EPS
-$0.08
Est. -$0.10Revenue
$19.26 M
Est. $18.72 MNext Earnings Call
Expected Date
March 10, 2027
EPS Estimate
-$0.03
Consensus analyst estimateRevenue Estimate
$24.78 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 17.84%▼ 53.68% |
|---|---|
| Total Invested | $22.58M▼ 84.65% |
| Investors Holding | 28▼ 123.00% |
About Codexis Inc.
146 employees
CEO: Alison Moore
Codexis, Inc. specializes in the invention, advancement, and commercialization of enzymes and various other proteins. Their diverse portfolio encompasses biocatalyst solutions, chemical intermediates designed for subsequent processing, a...